Building trust and diversity in patient-centered oncology clinical trials: An integrated model

scientific article published in February 2017

Building trust and diversity in patient-centered oncology clinical trials: An integrated model is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/1740774516688860
P698PubMed publication ID28166647

P2093author name stringCharles D Kaplan
Ernest T Hawk
Elise D Cook
Lovell A Jones
Janice A Chilton
Thelma C Hurd
Jay S Lytton
P2860cites workFeeling and thinking: Preferences need no inferences.Q29029582
Patients' trust in physicians: many theories, few measures, and little dataQ30607579
Key concepts relevant to quality of complex and shared decision-making in health care: a literature reviewQ34124416
Managing patient trust in managed careQ34146879
When is it rational to participate in a clinical trial? A game theory approach incorporating trust, regret and guiltQ34314845
Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango).Q34416426
Using a business model approach and marketing techniques for recruitment to clinical trialsQ34712827
African American women's perceptions of cancer clinical trials.Q34998611
Lessons learned about minority recruitment and retention from the Centers on Minority Aging and Health PromotionQ35072977
Trust and distrust in organizations: emerging perspectives, enduring questionsQ35687445
Marketing and clinical trials: a case studyQ36402162
Effectiveness of strategies to recruit underrepresented populations into cancer clinical trialsQ36506586
Removing barriers to participation in clinical trials, a conceptual framework and retrospective chart review studyQ36552760
Prior experiences of racial discrimination and racial differences in health care system distrustQ36553671
Clinical trials attitudes and practices of Latino physiciansQ36984227
Recruitment of minority and underserved populations in the United States: the Centers for Population Health and Health Disparities experience.Q37097058
Cancer patients' trust in their physician—a reviewQ37794093
Trust and the development of health care as a social institutionQ39024148
Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollmentQ40719431
Cancer trials versus the real world in the United States.Q42610091
Participation in cancer clinical trials: why are patients not participating?Q45827130
Distrust, race, and researchQ46863840
Feeling and believing: the influence of emotion on trustQ47273502
Deal done over HeLa cell lineQ48190962
Trust but verify: the interactive effects of trust and autonomy preferences on health outcomesQ48304814
Concepts of trust among patients with serious illnessQ50133365
Racial differences in trust in health care providers.Q50780799
Extending the bases of subjective attitudinal ambivalence: interpersonal and intrapersonal antecedents of evaluative tension.Q52140138
Trust and AntitrustQ56442337
Whence Univalent Ambivalence? From the Anticipation of Conflicting ReactionsQ56941415
P433issue2
P304page(s)170-179
P577publication date2017-02-01
P1433published inClinical TrialsQ5133802
P1476titleBuilding trust and diversity in patient-centered oncology clinical trials: An integrated model
P478volume14

Reverse relations

cites work (P2860)
Q55716334A review of strategies used to retain participants in clinical research during an infectious disease outbreak: The PREVAIL I Ebola vaccine trial experience.
Q58790116Ambivalence: A Key to Clinical Trial Participation?
Q55191154Patient-centered recruitment and retention for a randomized controlled study.
Q47298857Perspectives on Research Participation and Facilitation Among Dialysis Patients, Clinic Personnel, and Medical Providers: A Focus Group Study.
Q90218038When Will Clinical Trials Finally Reflect Diversity?

Search more.